AL Amyloid research hub

A CAR T trial for amyloid light chain amyloidosis (AL Amyloid)

This study is testing a new 'CAR T-cell' treatment for AL amyloidosis, a rare condition where abnormal proteins build up and damage organs. It's for people whose AL amyloidosis has come back or hasn't responded to previous treatments. Researchers want to see if these modified cells can fight the disease.